Pharmacokinetic/pharmacodynamic parameters for treatment optimization of infection due to antibiotic resistant bacteria: a summary for practical purposes in children and adults

Research output: Contribution to journalReview article


In the last years, there has been a tremendous increase in the incidence of bacterial infections due to resistant strains, especially multi-drug resistant Gram-negative bacilli. In Europe, a north to south and a west to east gradient was noticed, with more than one third of the K. pneumonia isolates being resistant to carbapenems in few countries. New antibiotics are lacking and, as a consequence, pharmacokinetic/pharmacodynamic parameters, normalized to pathogen minimal inhibitory concentration, are used with increased frequency to treat infections due to difficult-to-treat pathogens. These parameters are available at least for the adult population, but sparse in many different publications. This review wants to provide a comprehensive and 'easy to read' text for everyday practice, briefly summarizing the presently available knowledge on pharmacokinetic/pharmacodynamic parameters (normalized for minimal inhibitory concentration values) of different class drugs, that can be applied for an effective antibacterial treatment infections due to antibiotic-resistant pathogens.

Original languageEnglish
Pages (from-to)65-81
Number of pages17
JournalJournal of Chemotherapy
Issue number2
Publication statusPublished - Apr 2018



  • Adult
  • Anti-Bacterial Agents/pharmacokinetics
  • Bacteria/drug effects
  • Bacterial Infections/drug therapy
  • Child
  • Drug Resistance, Multiple, Bacterial/drug effects
  • Humans
  • Treatment Outcome

Cite this